Close Menu
Home » BioLegend Licenses Single-Cell Analysis Technology from New York Genome Center

BioLegend Licenses Single-Cell Analysis Technology from New York Genome Center

Jan 11, 2018
|
staff reporter

NEW YORK (GenomeWeb) – BioLegend has licensed a multidimensional single-cell analysis technology from the New York Genome Center and is collaborating with the center on further research, the two organizations said today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Metabolite Trail

The Economist reports that it is increasingly easier to analyze the metabolites people give off, potentially revealing personal information about them.

Not Meeting Standards

The Los Angeles Times reports that only a third of California students meet the state's new science standards.

Just a Few Changes...

A controversial paper on the gender gap in science has been corrected, according to BuzzFeed News.

Science Studies Examine Archaic Admixture in West Africans, Variant Linked to Cannabis Dependence Risk

In Science this week: evidence of interbreeding between the ancestors of West Africans and an unknown archaic human, and more.

What's Popular?

In Business News

  1. Bio-Rad Laboratories Products Indirectly Infringe 10x Genomics Patents, USITC Confirms

  2. OncoDNA Closes $20.6M Funding Round

  3. Yourgene Health Gets Australian Approval for Chemotoxicity Assay

  4. Exact Sciences Boosting Position in Cancer Dx Market Through M&A

    Premium

  5. Bio-Rad Q4 Revenues up 1 Percent, Miss Analysts' Estimates

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.